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BACKGROUND: Vitamin D is an essential nutrient requirement for adults and children for normal metabolism and maintenance of healthy bones. 
Its deficiency may disrupt homeostasis and contribute 
to systemic diseases, especially in obese patients. This 
study aimed to examine the effect of vitamin D on insulin, 
fasting  blood  glucose  (FBG) and  waist-hip ratio  (WHR) 
in  young  and obese  Saudi  females  with  pre-existing 
hypovitaminosis D. 
METHODS: The results of this study were based on 
prospective parallel randomised controlled clinical trial 
conducted at King Fahd University Hospital in which 30 
obese Saudi young females aging 18-23 years with pre-
existing vitamin D deficiency contributed. Participants were 
randomly assigned to either vitamin D supplementation 
group (experimental) or placebo group (control). Subjects of 
vitamin D group received 50,000 IU/week of cholecalciferol 
drops and placebo group received 10 mL of normal saline 
drops for 12 weeks. 
RESULTS: The results of multivariate repeated 
measures  analysis  showed  a  change  in  serum 
25-Hydroxycholecalciferol levels after vitamin D 
supplementation (F=296.132, p<0.05). There was also an 
indication of difference between the vitamin D group and 
placebo group. The only significant relationship was found 
between vitamin D and FBG (p<0.05). Supplementation 
of vitamin D improved FBG but did not contribute to 
improving insulin level. There was no association between 
vitamin D supplementation and WHR.     
CONCLUSION: This study concludes that supplementation 
of vitamin D improves FBG, but it has no contribution in 
improving insulin level. No association exists between 
vitamin D supplementation and WHR. The insignificant 
correlation of vitamin D intake with WHR and insulin can 
be attributed to the small sample size, therefore, further 
research is suggested with large sample size.
KEywORDS: vitamin D, fasting blood glucose, body 
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Abstract
Introduction
Vitamin D refers to a group of fat-soluble secosteroids, 
of which, the most important compounds are vitamin D3 
(cholecalciferol) and vitamin D2 (ergocalciferol). Vitamin 
D is primarily responsible for the intestinal absorption, 
homeostasis and metabolism of calcium in the body, which 
is an essential nutrient for healthy bones and teeth in both 
adults and children.(1) As imperative vitamin D is for proper 
growth of human body, its deficiency can cause serious 
health concerns, out of which bone loss and bone fracture 
are prominent degrading consequences. Its deficiency 
may also lead to rickets, osteomalacia and osteoporosis in 
children, adults and women respectively.(2) 
 The principal source of the vitamin D in our body is 
cholecalciferol synthesis in the skin, which starts through 
direct sun exposure. The ultraviolet-B (UVB) light from the 
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sun is absorbed by the skin that activates the synthesis of 
vitamin D. After its synthesis, it is regulated in the body 
by several factors which include intestinal absorption, renal 
function, serum calcium and parathyroid hormone (PTH) 
levels.(3) Any disturbance to aforementioned factors, from 
synthesis to regulation, can lead to the deficiency of vitamin 
D. In addition to these factors, other physical characteristics 
such as age, skinfold body thickness and weight also play 
significant role in vitamin D deficiency.(4) Since our skin 
is the main source of vitamin D synthesis, its pigmentation 
level also serves as an important factor in determining 
vitamin D concentration in the body.(5) For instance, darker 
skin (more pigmentation) hampers the absorption of UVB 
light from the sun into the skin (5-7), leading to reduced 
vitamin D synthesis and increasing the risk of its deficiency.
(6) Due to an excessive skin pigmentation, Asian population 
is at more risk of developing vitamin D deficiency than 
white population.(8)
 Another important factor that determines vitamin D 
status  in  the  body  is  Serum  25-hydroxy vitamin  D 
(25(OH)D) level. Its normal range is between 16 to 48 ng/
mL and its level under 8 ng/mL is considered to be the cause 
of rickets and osteomalacia.(7) Serum PTH levels are also 
important measures which determine vitamin D levels.(3) 
PTH is needed to stimulate bone mineralisation and it also 
increases the calcium concentration, needed for essential 
biological processes in the body such as muscle contraction 
and nerve conduction.(9) 
 Vitamin D deficiency is considered as one of the most 
common illnesses worldwide.(10)  Vitamin D deficiency is 
involved in several medical conditions such as poor bone 
development, common cancers, cardiovascular disease and 
diabetes.(9-11) In Saudi Arabia, for example, a number of 
studies have reported that although there is plentiful sunlight 
and sufficient supplementary products are available in the 
market, vitamin D level is still very low among various 
sections of the population.(3,7,12) An appreciable proportion 
(23%) of women suffer from vitamin D deficiency at the age 
of 50 and above.(13) 
 Unfortunately, the incidence of vitamin D deficiency 
is also increasing amongst younger obese women. This 
alarming condition can be attributed to certain cultural 
reasons such as clothing which limits skin exposure to 
sunlight. Lifestyle also plays a role in causing vitamin D 
deficiency such as sedentary lifestyle and poor diet.(12) The 
association of vitamin D deficiency with obesity has already 
been established in the literature. For instance, in a recent 
study, there are factors leading to vitamin D deficiency in 
obesity include sedentary lifestyle, low sunlight exposure 
or less outdoor activity, and vitamin D metabolism 
derangement due to its deposition in adipose tissues, and 
volumetric dilution.(14)
 In existing literature, most studies suggest that Vitamin 
D deficiency is more prevalent amongst women, teenagers 
and young children than men.(15) Among women, older age 
group is more likely to suffer from vitamin D deficiency 
manifested as osteoporosis and other systemic conditions 
such as diabetes.(16) Evidence also suggests that poor 
vitamin D level has been observed amongst younger 
women, which indicates that women in Saudi Arabia are 
developing serious conditions like osteoporosis before the 
age of menopause.(3,7,12) The situation becomes more 
serious in obese patients who are already prone to or possess 
vitamin D deficiency. Interestingly, no clinical study has 
been reported in Saudi Arabia so far that provides further 
insights on the effect of vitamin D supplementation on 
obese young females. 
 Current study aims to examine the difference of vitamin 
D level between the participants in the experimental group 
who received vitamin D and the control group who received 
placebo (10 mL of normal saline drops). The study aims to 
examine the association between post supplementation of 
vitamin D and placebo on insulin, fasting blood glucose 
(FBG) and waist-hip ratio (WHR) in young and obese Saudi 
females with pre-existing hypovitaminosis D.  
Methods
This study was conducted using prospective parallel 
randomised controlled clinical trial which was double 
blinded: patients and researchers. The pilot trial included 30 
obese (BMI>30 kg/m2) medical students with age ranging 
from 18 to 23 years; they also had pre-exiting vitamin D 
deficiency (serum 25(OH)D<20 ng/mL). Subjects who 
had a history of any endocrine disease (especially diabetes 
mellitus) or any systemic disease such as malabsorption, 
liver or renal disease were excluded from the study. Also 
excluded were the students who were pregnant and/
or lactating mothers, smokers, had a history of recent 
weight loss or who were already taking any medications 
or multivitamins. The study protocol was approved by the 
Research and Ethics Committee of King Fahd University 
Hospital (IRB No. KFHU/16-P012011).  
 Subjects were randomly assigned to either vitamin 
D group (receiving 50,000 IU/week of cholecalciferol 
drops) or Placebo group (receiving 10 mL of normal saline 
drops) for 12 weeks. A block randomization procedure with 
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serial entry in blocks was used.(17) Four participants were 
included in each block, ensuring that two students within 
each block were allocated to vitamin D group and two 
were allocated to placebo group. Subjects were advised to 
maintain their usual diet and avoid taking any vitamin D 
supplementation on their own throughout the trial period. 
They were also asked to inform the researcher if any other 
medication would be prescribed to them for any health issue 
during the trail. 
Blood Sampling
Venous blood samples were taken by a phlebotomist, using 
a sterile vacutainer. 10 mL of blood was collected from each 
participant (9 mL was collected in plain vacutainers for 
the preparation of serum samples and 1 mL of blood was 
collected in vacutainers buffered with EDTA anticoagulant 
for all blood samples. All students were asked to fast 
overnight (12 h with no food or beverage except water).(18) 
 The blood was allowed to clot for 30 min after 
extraction  and  then  centrifuged  for  20  min  at  3000 
rpm within 2 h.(19) After centrifugation, the serum was 
separated, and transferred to an Eppendorf tube, marked 
with identification code on sticker and stored at -80°C until 
the time of the analysis.  
 Fasting blood samples were obtained at the baseline 
(November 2016) and at the end of supplementation 
period of the study (February 2017).  The FBG level was 
measured and recorded through Accu-Check Glucometer 
(Roche Diagnostics, Indianapolis, USA), vitamin D level 
was assessed by measuring serum 25(OH)D level through 
Enzyme-linked Immunosorbent Assay (ELISA), and 
Plasma insulin was measured through insulin ELISA kit. 
Insulin sensitivity was calculated by homeostasis model 
assessment of insulin resistance (HOMA-IR) by (fasting 
plasma glucose x fasting insulin)/405. 
      
Statistical Analysis
The data collected throughout the course of this study was 
analysed in order to draw a comparison between the vitamin 
D and placebo group. Mean and standard deviation of all 
variables was calculated.  All analysis was performed using 
SPSS package 24.  
Results
Vitamin D
(n = 15)
Placebo
(n = 15)
Age (years) 19.7 (±0.72) 20.4 (±1.18) 0.050
BMI (kg/m2) 35 (±3.85) 32.2 (±2.99) 0.032
WHR 0.8 (±0.04) 0.8 (±0.06) 0.355
OHD (ng/mL) 2.9 (±0.93) 3 (±1.08) 0.700
FBG (mmol/L) 88.2 (±7.42) 85.4 (±8.81) 0.354
Insulin (pmol/L) 5.1 (±12.47) 6.3 (±12.75) 0.811
HOMA-IR 1.1 (±2.84) 1.2 (±2.26) 0.967
Mean (±SD)
p -value*
Table 1. Baseline characteristics of all participants (n=30).
BMI: body mass index; WHR: waist to hip ratio; OHD: hydroxyl 
vitamin D; FBG: fasting blood glucose; HOMA-IR: homeostatic 
model assessment of insulin resistance. *Analyzed by independent 
sample T-test.
characteristics of all participants is shown in Table 1. Those 
individuals assigned to the vitamin D group received 
vitamin D supplement while the second group received 
placebo. Comparison of BMI and metabolic risk factors before 
and after treatment was Table 2, meanwhile the comparison of 
mean differences was shown in Table 3.
 The results of the multiple regression model in Table 
4 demonstrated no significant relationship between the 
supplementation of vitamin D (post) and the explanatory 
factors (WHR and insulin, p>0.05). The only significant 
relationship was found between vitamin D and FBG 
(p<0.05). 
Discussion
This study aims to assess the impact of vitamin D 
supplementation on body parameters and metabolic factors 
such as WHR, insulin and FBG in obese young Saudi 
females. 
 The results demonstrated that the rise in FBG level 
in placebo group were more pronounced than incremental 
increase in the vitamin D group, as can be seen in Table 
2. This significant finding suggests that vitamin D has a 
potential role in controlling the level of plasma glucose. 
This is also in line with findings of Iyengar, et al., who 
reported clinical association between FBG and vitamin D 
levels. The authors stressed that vitamin D plays a critical 
role in regulating blood glucose level.(20) However, in 
another study, no relationship was found between vitamin D 
concentration and FBG, insulin or glucagon secretion.(21) 
According to the later, vitamin D levels and glucose control 
Descriptive Statistics of Vitamin and Placebo Groups
This study took a sample of 30 individuals who are divided 
into two groups (15 vitamin D and 15 placebo). The baseline 
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Table 2. Comparison of BMI and metabolic risk factors before and after treatment (n=30).
Baseline 12 weeks p -value* Baseline 12 weeks p -value*
WHR 0.8 (±0.04) 0.8 (±0.07) 0.277 0.8 (±0.06) 0.8 (±0.06) 0.135
OHD (ng/mL) 2.9 (±0.93) 31.3 (±9.22) 0.000 3 (±1.08) 5.7 (±1.64) 0.000
FBG (mmol/L) 88.2 (±7.42) 91 (±5.84) 0.208 85.4 (±8.81) 96 (±5.21) 0.001
Insulin (pmol/L) 5.1 (±12.47) 4.7 (±12.55) 0.146 6.3 (±12.75) 6.3 (±12.48) 0.964
HOMA-IR 1.1 (±2.84) 1.1 (±3.04) 0.629 1.2 (±2.26) 1.6 (±3.15) 0.218
Vitamin D (n=15) Placebo (n=15)
BMI: body mass index; WHR: waist to hip ratio; OHD: hydroxyl vitamin D; FBG: fasting blood glucose; HOMA-IR: 
homeostatic model assessment of insulin resistance. *Analyzed by paired T-test.
BMI: body mass index; WHR: waist to hip ratio; OHD: 
hydroxyl vitamin D; FBG: fasting blood glucose; HOMA-IR: 
homeostatic model assessment of insulin resistance. *Analyzed 
by independent sample T-test.
Vitamin D Placebo
WHR -0.02 (±0.1) -0.01 (±0.03) 0.648
OHD (ng/mL) 28.4 (±9) 2.63 (±1.67) 0.000
FBG (mmol/L) 2.8 (±8.2) 10.6 (±9.99) 0.027
Insulin (pmol/L) -0.46 (±1.2) 0.03 (±2.57) 0.503
HOMA-IR -0.04 (±0.3) 0.37 (±1.11) 0.190
Mean Differences (±SD)
(Post – Pre) p -value
Table 3. Comparison of mean differences (post and pre-
treatment) (n=30).
in healthy individuals are independent variables and they 
have no effect on each other.  
 The results of this study found no significant 
relationship between vitamin D and insulin resistance 
(p>0.05). This finding is contrary to the findings of Nagpal 
and colleagues who reported inverse relationship between 
vitamin D concentration and insulin resistance.(22) The 
main reason for this finding is the obesity characteristic 
of our subjects as obesity is directly related to insulin 
resistance.(23,24) Another reason for such finding could be 
the small sample size used in this trial. A larger population 
size could have produced different results.
 Despite this, the association between the vitamin 
D supplementation and insulin resistance has remained 
controversial in the literature.(25-27) Most of these studies 
have used cross-sectional approach and recommended 
the randomised clinical trials design. This current study, 
through a randomised control clinical trial, showed no 
significant relationship between vitamin D levels and 
insulin resistance.  On  the  contrary,  several  other  studies 
have  found  a  clear  association  between  vitamin  D  and 
insulin secretion.(22,28)  
 With regards to WHR variable, the multiple regression 
model indicated no relationship with vitamin D (p>0.05). 
The findings of current study are interesting because there 
are several studies which state otherwise.  For instance, 
Wehr, et al., revealed negative correlation between the 
supplementation of vitamin D and WHR.(29) Similarly, 
another study reported that vitamin D supplementation 
in overweight and obese female adults was associated 
with lower WHR.(30) The present findings could be due 
to the small sample size used in the trial. Nonetheless, 
the  insignificant  relationship between vitamin  D 
supplementation  and  WHR  has  also  been reported 
previously  by  several  other  studies.(24,31,32) 
 Although, no significant relationship was found in the 
current study, Semba, et al., stressed that weight factors such 
as high BMI and high body skin thickness may be regarded 
as  predictors  of  vitamin  D  levels  among women.(33) 
Many  studies  who  suggest  a  clear  association  between 
obesity  and  vitamin  D  status  have  reported  that  obesity 
causes alteration in vitamin D metabolism, leading to 
decreased  vitamin  D  absorption  in  obese  individuals.
(34-36)
 The positive correlation of vitamin D with FBG 
has huge clinical significance. This finding suggests that 
obese females who suffer from vitamin D deficiency 
are more prone to diabetes mellitus. Numerous studies 
have concluded similar findings by associating vitamin D 
deficiency with the higher occurrence rate of diabetes in 
non-obese individuals.(37,38) Our study stresses on the 
issue that vitamin D deficiency may aggravate the existing 
condition or increase the chances of developing diabetes in 
young obese females. This conclusion has higher relevance 
to Saudi population as vitamin D deficiency is relatively 
common in them due to cultural norms.
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Standardized 
Coefficients
Beta Std. Error Beta
(Constant) 107.195 62.081 - 1.727 0.097
Post WHR 5.264 45.702 0.023 0.115 0.909
Post Insulin 0.13 0.239 0.11 0.545 0.591
Post FBG 1.09 0.517 0.449 2.109 0.046
Unstandardized 
Coefficients T Sig.
Table 4. Regression coefficients model.
Conclusion
It can be concluded from the results of this study that 
supplementation of vitamin D improves FBG but it has 
no contribution to improving insulin level. The study also 
concludes that no association exists between vitamin D 
supplementation and WHR.  
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